Direct Oral Anticoagulants and Cancer-Associated Thrombosis Management. Where Do We Stand in 2019?

Autor:	Eduardo Ramacciotti MD, PhD, Leandro B. Agati PhD, Roberto Augusto Caffaro MD, PhD, Giuliano G. Volpiani MD, Renato D. Lopes MD, PhD, Anthony J. Comerota MD, Jawed Fareed PhD
Jazyk:	angličtina
Rok vydání:	2019
Předmět:	Diseases of the circulatory (Cardiovascular) system RC666-701
Zdroj:	Clinical and Applied Thrombosis/Hemostasis, Vol 25 (2019)
Druh dokumentu:	article
ISSN:	1938-2723 10760296
DOI:	10.1177/1076029619856433
Popis:	Direct oral anticoagulants (DOACs) are now widely used for the management of venous thromboembolism (VTE) that now includes cancer-associated thrombosis. This review summarizes recent data on VTE prophylaxis and treatment, new challenges, guidelines, and updates as well as the current place for DOACs on the emerging cancer-associated VTE management landscape.
Databáze:	Directory of Open Access Journals
Externí odkaz:	https://doaj.org/article/31886d6b21ec4630961d797b7c05ea41 Zobrazit plný text záznamu View record in DOAJ